...
首页> 外文期刊>International Journal of Nanomedicine >The Biological Activity Research of the Nano-Drugs Based on 5-Fluorouracil-Modified Quantum Dots
【24h】

The Biological Activity Research of the Nano-Drugs Based on 5-Fluorouracil-Modified Quantum Dots

机译:基于5-氟尿嘧啶改性量子点的纳米药物生物学活性研究

获取原文

摘要

Purpose: Over the past decades, quantum dots (QDs) have shown the broad application in diverse fields, especially in intracellular probing and drug delivery, due to their high fluorescence intensity, long fluorescence lifetime, strong light-resistant bleaching ability, and strong light stability. Therefore, we explore a kind of therapeutic potential against cancer with fluorescent imaging. Methods: In the current study, a new type of QDs (QDs@L-Cys-TAEA-5-FUA) capped with L-cysteine (L-Cys) and tris(2-aminoethyl)amine (TAEA) ligands, and conjugated with 5-fluorouracil-1-acetic acid (5-FUA) has been synthesized. Ligands were characterized by electrospray ionization mass spectrometry?and H-nuclear magnetic resonance (sup1/supH NMR) spectroscopy. The modified QDs were characterized by transmission electron microscopy, ultraviolet and visible spectrophotometry (UV-Vis), and fluorescence microscopy. And the biological activity of modified QDs was explored by using MTT assay with HeLa, SMMC-7721 HepG2, and QSG-7701 cells. The fluorescence imaging of modified QDs was obtained by fluorescence microscope. Results: The modified QDs are of controllable sizes in the range of 4– 5 nm and they possess strong optical emission properties. UV-Vis and fluorescence spectra demonstrated that the L-Cys-TAEA-5-FUA was successfully incorporated into QD nanoparticles. The MTT results demonstrated that L-Cys-TAEA-5-FUA modified QDs could efficiently inhibit the proliferation of cancer cells as compared to the normal cells, illustrating their antitumor efficacy. The mechanistic studies revealed that the effective internalization of modified QDs inside cancer cells could inhibit their proliferation, through excessive production of intracellular reactive oxygen species, leading to apoptosis process. Conclusion: The present study suggests that modified QDs can enter cells efficiently and could be employed as therapeutic agents for the treatment of various types of cancers with fluorescent imaging.
机译:目的:在过去的几十年中,量子点(QDS)在各种领域中显示了广泛的应用,尤其是细胞内探测和药物递送,由于它们的高荧光强度,长荧光寿命,强烈的耐耐光性漂白能力和强光稳定。因此,我们探索一种荧光成像对抗癌症的一种治疗潜力。方法:在目前的研究中,用L-半胱氨酸(L-Cys)和Tris(2-氨基乙基)胺(Taea)配体封装了一种新型的QD(QDS @ L-Cys-Taea-5-FUA),并缀合合成了5-氟尿嘧啶-1-乙酸(5-FUA)。通过电喷雾电离质谱法表征配体α和H核磁共振( 1 H NMR)光谱。通过透射电子显微镜,紫外线和可见分光光度法(UV-VI)和荧光显微镜,其特征在于改性的QD。通过使用Hela,SMMC-7721 HepG2和QSG-7701细胞使用MTT测定来探索改性QD的生物活性。通过荧光显微镜获得改性QD的荧光成像。结果:改性的QD在4-5nm的范围内具有可控尺寸,它们具有强光发射特性。 UV-Vis和荧光光谱证明了L-Cys-Taea-5-FUA成功掺入QD纳米粒子中。 MTT结果表明,与正常细胞相比,L-Cys-Taea-5-Fua改性QD可以有效地抑制癌细胞的增殖,说明其抗肿瘤功效。机械研究表明,通过过度生产细胞内反应性氧物种,癌细胞内改性QD的有效内化可以抑制它们的增殖,导致细胞内反应性氧。结论:本研究表明,修饰的QD可以有效进入细胞,可用作治疗各种类型的荧光成像的治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号